chlorambucil has been researched along with antimony in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baum, C; Fodstad, Ø; Hildinger, M; Lorico, A; Rappa, G | 1 |
1 other study(ies) available for chlorambucil and antimony
| Article | Year |
|---|---|
Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents.
Topics: 3T3 Cells; Alkylating Agents; Animals; Antimony; Blotting, Southern; Cells, Cultured; Chlorambucil; Cisplatin; Cloning, Molecular; DNA, Complementary; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Fibroblasts; Flow Cytometry; Friend murine leukemia virus; Genetic Therapy; Genetic Vectors; Genome, Viral; Glutamate-Cysteine Ligase; Glutathione; Hematopoietic Stem Cells; Humans; Inhibitory Concentration 50; Male; Melphalan; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Multidrug Resistance-Associated Proteins; Retroviridae; RNA; RNA, Messenger; Terminal Repeat Sequences; Transduction, Genetic; Viral Envelope Proteins | 2001 |